1108 – 13351 Commerce Parkway
Member Sector: Medical Devices
bioLytical Laboratories Inc. based in Richmond, BC, Canada is a privately-owned Canadian company focused on the research, development and commercialization of rapid, point-of-care in vitro medical diagnostics using its proprietary INSTI™ technology platform.
With a world-wide footprint of regulatory approvals including US FDA approval, Health Canada approval and CE mark, bioLytical markets and sells its INSTI™ HIV test globally and INSTI™ HIV/Syphilis Multiplex test in Europe. The INSTI product line provides highly accurate test results in 60 seconds or less, far faster than the 15-20 minutes required for tests based on lateral flow technology.
As an incredibly nimble and innovative company, bioLytical has an active R&D department with a pipeline that includes INSTI™ tests for diseases such as Hepatitis C, Hepatitis B and Ebola among others. The company also provides contract services to adapt the INSTI™ platform to meet custom functional and technical diagnostic testing requirements.